Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal francais d'ophtalmologie"
DOI: 10.1016/j.jfo.2018.02.001
Abstract: New anticancer therapies, immune pathway inhibitors, may cause immune-related adverse events (IRAE). Immune-related ocular toxicities are rare but are potentially serious adverse events. The purpose of this article is to report a case of ocular…
read more here.
Keywords:
nivolumab therapy;
uveitis associated;
associated nivolumab;
therapy ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Revista de neurologia"
DOI: 10.33588/rn.7002.2019153
Abstract: Miastenia grave asociada a nivolumab.
read more here.
Keywords:
myasthenia gravis;
gravis associated;
associated nivolumab;
Sign Up to like & get
recommendations!
0
Published in 2022 at "Dermatology online journal"
DOI: 10.5070/d328357786
Abstract: Nivolumab is a programmed death-1 (PD1) immune checkpoint inhibitor that treats various types of cancers including non-small cell lung carcinoma and melanoma, among others. Although it serves as an effective immunotherapy, there are many associated…
read more here.
Keywords:
cell carcinoma;
cell;
associated nivolumab;
melanoma ... See more keywords